Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bikash Medhi and Phulen Sarma.
Bikash Medhi
Connection Strength
12.800
Phulen Sarma
  1. Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol. 2020 Nov-Dec; 52(6):535-550.
    View in: PubMed
    Score: 0.911
  2. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). J Biomol Struct Dyn. 2021 05; 39(8):2724-2732.
    View in: PubMed
    Score: 0.883
  3. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. J Med Virol. 2020 07; 92(7):776-785.
    View in: PubMed
    Score: 0.880
  4. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Indian J Pharmacol. 2020 Jan-Feb; 52(1):1-5.
    View in: PubMed
    Score: 0.871
  5. Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy. Indian J Pharmacol. 2018 Jan-Feb; 50(1):1-3.
    View in: PubMed
    Score: 0.749
  6. Cosmetovigilance in India: Need of the day. Indian J Pharmacol. 2017 Sep-Oct; 49(5):341-343.
    View in: PubMed
    Score: 0.731
  7. Update on geographical variation and distribution of SARS-nCoV-2: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):310-316.
    View in: PubMed
    Score: 0.238
  8. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):317-327.
    View in: PubMed
    Score: 0.238
  9. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis. Sci Rep. 2021 06 18; 11(1):12888.
    View in: PubMed
    Score: 0.238
  10. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review. Phytother Res. 2021 Aug; 35(8):4456-4484.
    View in: PubMed
    Score: 0.238
  11. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review. Eur J Pharmacol. 2021 Sep 05; 906:174233.
    View in: PubMed
    Score: 0.237
  12. Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD. Comput Biol Med. 2021 07; 134:104495.
    View in: PubMed
    Score: 0.236
  13. Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings. J Biomol Struct Dyn. 2021 May 13; 1-11.
    View in: PubMed
    Score: 0.236
  14. Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review. Indian J Pharmacol. 2021 May-Jun; 53(3):236-243.
    View in: PubMed
    Score: 0.236
  15. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann Intern Med. 2021 03; 174(3):434.
    View in: PubMed
    Score: 0.233
  16. Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses. 2021 Apr; 149:110539.
    View in: PubMed
    Score: 0.233
  17. Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review. Biomed Pharmacother. 2021 May; 137:111300.
    View in: PubMed
    Score: 0.232
  18. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell. 2021 Jun; 70:101497.
    View in: PubMed
    Score: 0.232
  19. Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep. 2021 Jun; 73(3):736-749.
    View in: PubMed
    Score: 0.230
  20. Indian contribution toward biomedical research and development in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jan-Feb; 53(1):63-72.
    View in: PubMed
    Score: 0.230
  21. In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations. mSystems. 2020 Sep 22; 5(5).
    View in: PubMed
    Score: 0.226
  22. Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence. Vet Res Commun. 2020 Nov; 44(3-4):119-130.
    View in: PubMed
    Score: 0.226
  23. Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients. Indian J Pharmacol. 2020 Sep-Oct; 52(5):414-421.
    View in: PubMed
    Score: 0.225
  24. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model. 2020 12; 101:107716.
    View in: PubMed
    Score: 0.225
  25. Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review. Life Sci. 2020 Oct 01; 258:118207.
    View in: PubMed
    Score: 0.224
  26. Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2. Graefes Arch Clin Exp Ophthalmol. 2020 11; 258(11):2575-2578.
    View in: PubMed
    Score: 0.224
  27. Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol. 2020 Jul-Aug; 52(4):313-323.
    View in: PubMed
    Score: 0.223
  28. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virol Sin. 2020 Jun; 35(3):290-304.
    View in: PubMed
    Score: 0.222
  29. Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown. Indian J Pharmacol. 2020 Mar-Apr; 52(2):75-78.
    View in: PubMed
    Score: 0.221
  30. COVID-19 pandemic: A review based on current evidence. Indian J Pharmacol. 2020 Mar-Apr; 52(2):117-129.
    View in: PubMed
    Score: 0.221
  31. Update on the target structures of SARS-CoV-2: A systematic review. Indian J Pharmacol. 2020 Mar-Apr; 52(2):142-149.
    View in: PubMed
    Score: 0.221
  32. Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV. Graefes Arch Clin Exp Ophthalmol. 2020 11; 258(11):2563-2565.
    View in: PubMed
    Score: 0.221
  33. Drug targets for corona virus: A systematic review. Indian J Pharmacol. 2020 Jan-Feb; 52(1):56-65.
    View in: PubMed
    Score: 0.218
  34. Modulation of endocannabinoid system: Success lies in the failures. Indian J Pharmacol. 2018 Jul-Aug; 50(4):155-158.
    View in: PubMed
    Score: 0.194
  35. mHealth technologies in clinical trials: Opportunities and challenges. Indian J Pharmacol. 2018 May-Jun; 50(3):105-107.
    View in: PubMed
    Score: 0.191
  36. Intellectual property rights and Indian pharmaceutical industry: Present scenario. Indian J Pharmacol. 2018 Mar-Apr; 50(2):57-60.
    View in: PubMed
    Score: 0.189
  37. Three-dimensional drugs: A new era in the pharmaceutical development. Indian J Pharmacol. 2017 Nov-Dec; 49(6):417-418.
    View in: PubMed
    Score: 0.185
  38. Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review. Front Pharmacol. 2017; 8:754.
    View in: PubMed
    Score: 0.185
  39. Orphan drugs: Indian perspective. Indian J Pharmacol. 2017 Jul-Aug; 49(4):267-269.
    View in: PubMed
    Score: 0.181
  40. Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient. J Pharmacol Pharmacother. 2017 Jul-Sep; 8(3):148-150.
    View in: PubMed
    Score: 0.181
  41. Congenital malformation and autism spectrum disorder: Insight from a rat model of autism spectrum disorder. Indian J Pharmacol. 2017 May-Jun; 49(3):243-249.
    View in: PubMed
    Score: 0.179
  42. Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review. J Biomol Struct Dyn. 2020 Dec 10; 1-16.
    View in: PubMed
    Score: 0.057
  43. Therapeutic potential of arachidonyl trifluromethyl ketone, a cytosolic phospholipaseA2 IVA specific inhibitor, in cigarette smoke condensate-induced pathological conditions in alveolar type I & II epithelial cells. Toxicol In Vitro. 2019 Feb; 54:215-223.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.